Develop/manufacture transformational medication technologies/services for patient care
Pharmaceutical patent issues, including related provisions in H.R. 9, the Innovation Act, S. 1137, the PATENT Act, and H.R.3678, the Preserving Access to Orphan Drugs Act of 2015. Legislative issues related to the FDA Regulation of Biosimilars. Diabetes Prevention & Treatment, including related provisions of HR 2651, The Eliminating Disparities in Diabetes Prevention, Access and Care Act of 2013 and HR 1192, The National Diabetes Clinical Care Commission Act. Medicare Coverage and Reimbursement issues, including the CMS Part B Drug Demonstration Proposed Rule; Medicare access to DXA services, including HR 2461, and legislative issues related to the CMS 2017 Hospital Outpatient Prospective Payment proposed rule; Medicare reimbursement for antimicrobial drugs, including related provisions in HR 512, The Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2014.
CPT - Copyright/Patent/Trademark HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
CAPITOL COUNSEL LLC
700 13th Street NW, 2nd Floor, Washington, DC, 20005, US
SHANNON FINLEY JOHN D RAFFAELLI JAMES O MCCRERY DREW GOESL AARON COHEN LUKE HATZIS DENISE HENRY MORRISEY CHARLES TOWNER FRENCH MARTIN B. GOLD DAVID OLANDER SHANNON FINLEY DENISE HENRY MORRISEY SARA FRANKO JOHN D RAFFAELLI DREW GOESL AARON COHEN LUKE HATZIS CHARLES TOWNER FRENCH MARTIN B. GOLD SHANNON FINLEY DENISE HENRY MORRISEY SARA FRANKO JOHN D RAFFAELLI DREW GOESL AARON COHEN LUKE HATZIS CHARLES TOWNER FRENCH MARTIN B. GOLD